Ameriprise’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8M | Buy |
|
|||||
|
2025
Q1 | $14M | Sell |
|
|||||
|
2024
Q4 | $22M | Sell |
|
|||||
|
2024
Q3 | $223M | Sell |
|
|||||
|
2024
Q2 | $336M | Buy |
|
|||||
|
2024
Q1 | $172M | Buy |
|
|||||
|
2023
Q4 | $52.4M | Sell |
|
|||||
|
2023
Q3 | $56.1M | Buy |
|
|||||
|
2023
Q2 | $56.6M | Sell |
|
|||||
|
2023
Q1 | $58.6M | Buy |
|
|||||
|
2022
Q4 | $34.3M | Buy |
|
|||||
|
2022
Q3 | $32.2M | Sell |
|
|||||
|
2022
Q2 | $24.5M | Sell |
|
|||||
|
2022
Q1 | $32.8M | Sell |
|
|||||
|
2021
Q4 | $160M | Buy |
|
|||||
|
2021
Q3 | $108M | Buy |
|
|||||
|
2021
Q2 | $65.6M | Sell |
|
|||||
|
2021
Q1 | $55.4M | Buy |
|
|||||
|
2020
Q4 | $24.3M | Sell |
|
|||||
|
2020
Q3 | $36M | Buy |
|
|||||
|
2020
Q2 | $33.7M | Sell |
|
|||||
|
2020
Q1 | $57.3M | Sell |
|
|||||
|
2019
Q4 | $58.1M | Sell |
|
|||||
|
2019
Q3 | $51.5M | Sell |
|
|||||
|
2019
Q2 | $59.2M | Sell |
|
|||||
|
2019
Q1 | $137M | Sell |
|
|||||
|
2018
Q4 | $661M | Sell |
|
|||||
|
2018
Q3 | $1.06B | Buy |
|
|||||
|
2018
Q2 | $806M | Buy |
|
|||||
|
2018
Q1 | $714M | Sell |
|
|||||
|
2017
Q4 | $831M | Buy |
|
|||||
|
2017
Q3 | $723M | Buy |
|
|||||
|
2017
Q2 | $464M | Sell |
|
|||||
|
2017
Q1 | $512M | Sell |
|
|||||
|
2016
Q4 | $1.01B | Buy |
|
|||||
|
2016
Q3 | $1.1B | Sell |
|
|||||
|
2016
Q2 | $894M | Sell |
|
|||||
|
2016
Q1 | $1.07B | Buy |
|
|||||
|
2015
Q4 | $1.22B | Buy |
|
|||||
|
2015
Q3 | $1.11B | Buy |
|
|||||
|
2015
Q2 | $1.06B | Sell |
|
|||||
|
2015
Q1 | $1.37B | Buy |
|
|||||
|
2014
Q4 | $940M | Buy |
|
|||||
|
2014
Q3 | $854M | Sell |
|
|||||
|
2014
Q2 | $814M | Sell |
|
|||||
|
2014
Q1 | $808M | Buy |
|
|||||
|
2013
Q4 | $686M | Buy |
|
|||||
|
2013
Q3 | $521M | Sell |
|
|||||
|
2013
Q2 | $547M | Buy |
|